Pharm - Asthma, Tb, Ca Flashcards
Albuterol
Short acting beta 2 agonist
Quick onset of action
As needed for symptomatic relief
Oral or inhaled
What is the deal with aerosolized drugs for asthma?
90% actually swallowed
Should be poorly absorbed from GI tract or inactivated by first pass hepatic metabolism
Salmeterol
Long acting beta 2 agonist - Only inhaled
Moderate persistent and severe asthma
Slow onset of action and longer duration - not for acute
Slows diffusion away from receptor
Don’t use alone - use with inhaled corticosteroid
Who are inhaled corticosteroids recommended for?
Patients with persistent asthma that require short acting beta 2 agonist more than once a day
How do glucocorticoids work in the treatment of asthma?
Receptor once bound migrates to cytoplasm and inhibits NFkappaB and nucleus and inhibits AP1 involved in pro inflammatory genes, also activates anti inflammatory genes
Fluticasone
Inhaled glucocorticoid - prophylactic
Don’t reverse acute symptoms - mainstay for chronic asthma
One week onset with several months of effect
Minor side effects at high doses - oropharyngeal candidiasis, decreases in bone density, thinning of skin, purpura, dysphonia
Prednisone
Oral and systemic glucocorticoids
Management of severe episodes lasting days or chronic asthma
Same side effects as inhaled corticosteroids plus major - adrenal insufficiency from withdrawal on discontinuation, others
Cromolyn sodium and nedocromil sodium
Inhibit degranulation of pulmonary mast cells
Also reduce response of inflammatory cells
Mainly prophylactic - less effective than steroids
Only inhaled
Infrequent and minor side effects - bronchospasm, cough, laryngeal edema, joint swelling and pain, angioedema, headache, rash and nausea
Zafirlukast and montelukast
Competitive inhibitor of leukotriene receptor type 1
Normal activation would cause smooth muscle contraction
Zileuton
Inhibits 5 lipoxygenase - blocks conversion of arachidonic acid to leukotrienes
Leukotriene inhibitors in general
All oral
Metabolized in liver
Zafirlukast - some GI disturbances, mild headache, and increased amino transferase activity
Montelukast - few adverse effects
Zileuton - elevated liver alanine amino transferase can cause symptomatic hepatitis on stopping, monitor AT activity, dyspepsia
Theophylline
Possible inhibition of cAMP phosphodiesterase and competitive antagonism of adenosine receptors
Relaxes bronchial smooth muscle, other modest effects
Absorbed from GI, metabolism in liver
Lots of side effects - GI distress, anxiety, insomnia, headache, CNS effects and cardiac rhythm disturbances
Third line therapy in US but is inexpensive
Omalizumab
Anti IgE - cant bind to receptors on mast cells and basophils
Reduces both early and late phase response to allergens
Single SC injection every 2-4 weeks, dose adjusted based on serum IgE and body weight
Generally well tolerated - maybe anaphylaxis and increased cancer
Who is omalizumab indicated for?
Adults and adolescents >12 with allergies and persistent mild or moderate asthma
Why is tb so difficult to treat?
Difficult for drugs to penetrate mycolic acid cell wall
Mycobacteria have efflux pumps
Mycobacteria often sequestered within host cells
What is the general treatment for tb before and after drug susceptibility testing?
Before - RIPE
after - at least 3 to which sensitive for first 2 months
What is the current protocol for active tb?
2 months on RPI (initial phase) followed by 4 months on RI (continuation phase)
Substitute other first lines as needed based on sensitivity
Use directly observed therapy
When is chemo prophylaxis with isoniazid for 6 months recommended?
Household contacts of tb
Upon conversion to positive skin test with no symptoms
Patients with inactive tb who have never been adequately treated
What is MDR tb?
Resistant to R and I
What is XDR tb?
Resistant to R, I, fluoroquinolones, and at least one injectable second line agent
Isoniazid - mechanism of action
Most active anti tb drug, Bacteriostatic or cidal
Use confined to m. Tb and atypical mycobacteria
Prodrug - activated by myco bacterial catalase peroxidase katG
Radical adduct with NAD+ inhibits two steps in mycolic acid synthesis by inhA and kasA
NADP+ adduct inhibits mycobacterial DHFR
Isoniazid - mechanism of resistance
Lack katG catalase activity
Isoniazid - adverse effects
Two forms of enzyme lead to fast or slow acetylation - adjust dosage
Peripheral neuropathy - avoid by coadmin of pyridoxine
Hepatic toxicity - esp if over 50
Rifampin - mechanism of action
Inhibits prokaryotic DNA directed RNA polymerase
Activity against gram+ and gram-
Rifampin - resistance
Mutations in rpoB gene in tb
Rifampin - adverse effects
Sometimes hepatotoxic
Potent inducer of p450 - other drugs can fail due to increased metabolism
Rifabutin used in patients taking many other drugs
Pyrazinamide - mechanism of action
Activated to pyrazinoic acid by nicotinamidase (from pncA gene)
Growing cells can’t synthesize proteins
Semi dormant or starving cells can’t perform trans-translation
What is trans-translation?
Cells not able to grow well can stall on mRNA and it degrades
Stalled ribosomes bind tmRNA which can free it for productive translation
TmRNA also provide degradation signal on incompleted protein